Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v) Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare



Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v) Tablet — manufactured by Trumac Healthcare

Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v) Tablet

WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India

Salt: Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v)
Form: Tablet
Class: 4th-gen fluoroquinolone + difluorinated corticosteroid
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ 1 Brand Options

Pricing, brochure & monopoly territory within 24 hrs.

Our Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v) Tablet Brand Options (1 option)

Trumac Healthcare manufactures and supplies the following Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v) Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.

Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v) Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.

Therapeutic Indications
  • Post-operative ocular inflammation
  • Severe inflamed bacterial keratitis
  • Anterior uveitis with infection risk
Mechanism of Action

Moxifloxacin is a 4th-generation fluoroquinolone that inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, halting bacterial DNA replication. Its 8-methoxy substitution gives enhanced Gram-positive, atypical and anaerobic coverage with reduced resistance development. Difluprednate is a high-potency difluorinated corticosteroid with approximately 3-fold higher glucocorticoid receptor affinity than prednisolone and superior corneal penetration.

Dosage & Administration
  • 1 drop 4 times daily for 2 weeks, tapering over the next 2 weeks
  • Monitor IOP throughout treatment
  • Use under ophthalmologist supervision
Side Effects
  • Increased IOP (more frequent with difluprednate)
  • Cataract progression
  • Stinging
  • Eye pain
Contraindications
  • Viral or fungal ocular infection
  • Glaucoma
  • Hypersensitivity to either component
Storage

Store below 25°C.

PCD Pharma Franchise for Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v) Tablet

  • ✓ WHO-GMP certified manufacturing facility
  • ✓ Pan-India monopoly distribution rights available
  • ✓ Multiple pack sizes: 5ml
  • ✓ Trade-friendly PTR / PTS margins
  • ✓ Free promotional material on request
  • ✓ Full DCGI documentation and quality certificates supplied

Trumac Healthcare offers 1 brand option for Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v) Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.

For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v) Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.

Frequently Asked Questions

Who is the manufacturer of Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v) Tablet?

Trumac Healthcare is a WHO-GMP certified manufacturer of Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v) Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.

Is Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v) Tablet available for PCD pharma franchise on monopoly basis?

Yes. We offer Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v) Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.

What pack sizes are available for Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v) Tablet?

Available pack sizes include: 5ml.

What is the MRP / trade price for Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v) Tablet?

MRPs range from ₹145 to ₹145 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.

How do I place an order or franchise enquiry?

WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.

Ready to start your PCD franchise for Moxifloxacin (0.5%w/v) + Difluprednate (0.05%w/v) Tablet?

Get Pricing & Franchise Terms →